世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000043036

2025〜2030年のインドの分子診断市場 - 2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

VPGMarketResearch

2025-2030 India Molecular Diagnostics Market: 2025 Supplier Shares, Analyzer Installed Base and Strategies, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

発刊日 2025/11/15

言語英語

体裁PDF

ライセンス/価格

0000043036

Local PDF
Global PDF

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

LeadingMarketResearch.com のこのデータベースは、感染症、遺伝性疾患、がん診断、法医学および親子鑑定アプリケーションに関する2024年のサプライヤーシェア、2024 〜 2028年の数量と売上予測、および主要な検査用の新技術や製品を開発または販売している企業の包括的なリストを提供します。

主要企業

  • Abbott
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Cepheid/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Decode Genetics
  • Diasorin
  • 栄研化学(Eiken Chemical)
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ(Fujirebio)
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • LabCorp/Sequenom
  • Leica Biosystems/Kreatech
  • Li-Cor Biosciences
  • Myriad Genetics
  • Proteome Sciences
  • Qiagen
  • Quest Diagnostics
  • QuidelOrtho
  • Roche
  • 島津製作所(Shimadzu)
  • Siemens Healthineers
  • タカラバイオ(Takara Bio)
  • Tecan Group
  • Thermo Fisher

レポート詳細

図表

List of Tables
Molecular Diagnostics Test Volume and Sales Forecasts by Major Application
Molecular Diagnostics Test Volume by Major Application
Major Infectious Disease Test Volume by Assay
Major Infectious Disease Test Volume by Method
Molecular Diagnostics Market by Major Application
Major Infectious Disease Diagnostics Market by Assay
Major Companies Developing or Marketing Salmonella Molecular Diagnostic Tests
Major Companies Developing or Marketing AIDS Molecular Diagnostic Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic tests
Major Companies Developing or Marketing EBV Molecular Diagnostic Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases

この商品のレポートナンバー

0000043036

最近見たレポート

2018年版 太陽光発電市場・技術の実態と将来展望

− 基幹電源としての太陽光発電 〜 地産地消・太陽光発電市場実態予測・関連部材 −

将来展望シリーズ 〜 Solar-Power編

2018/01/26

77,000 円(税込)

2018 ビデオ会議/Web会議の最新市場とクラウドビデオコミュニケーションの現状

〜クラウドサービス、AI、新規ビジネス、働き方改革との関連〜

2018/03/26

154,000 円(税込)

2020 教育ICTの最新市場動向

〜全国の教育委員会のICT導入状況と教育ソリューション動向〜

2019/09/25

132,000 円(税込)

妊娠トラッキング・産後ケアアプリの世界市場規模調査・予測:用途別、デバイス別、プラットフォーム別、地域別の分析(2022年〜2029年)

Global Pregnancy Tracking and Postpartum Care Apps Market Size study & Forecast, by Application (Pre-partum, Post-partum), by Device (Smartphones, Tablets), by Platform (Android, iOS) and Regional Analysis, 2022-2029

2023/03/06

4,950 USD

2023年版 携帯電話市場の将来動向分析

― 法人モバイル通信、法人ソリューション、IoT通信サービスに焦点を当てた市場レポート ―

2023/08/10

209,000 円(税込)

腎臓バイオマーカー市場 (2025年 - 2033年)

Renal Biomarkers Market (2025 - 2033)

2025/10/01

5,950 USD

TOP